Defechereux T, Hamoir E, Nguyen Dang D, Meurisse M
Service de Chirurgie des Glandes Endocrines et Transplantation, Centre Hospitalier Universitaire de Liège, Belgique.
Ann Chir. 1997;51(6):647-52; discussion 653.
Drainage in thyroid surgery has been a routine but empirical practice with no scientific evidence to support its benefit. A retrospective review of a personal series of 1789 thyroidectomies over a 3 1/2-year period was conducted. Except for thyroid cancer surgery with lymphadenectomy and large mediastinal goiters requiring sternotomy, no case selection for non-drainage was employed. Patients were stratified only on a chronological basis, according to whether key were drained (n = 575, 1993-1994) or not drained (n = 1214, 1994-1996). Both series included toxic goiters, large plunging compressive goiters, bilateral and redo procedures. Severe life-threatening hematoma requiring reexploration occurred in 5 drained patients (0.9%) and in 5 undrained patients (0.4%). Minor postoperative wound hematoma were conservatively treated in 17 drained patients (2.9%) and 6 undrained patients (1.3%). In our experience, drainage after thyroid surgery may not mandatory provided that the field is completely dry before closure. We therefore, progressively modified our operative strategy in order to improve a meticulous haemostatic technique, considered to be more important than the use of drains. Meticulous surgical technique and obliteration of dead space led us to observe a dramatic decrease of the incidence of hemorrhagic complications, eliminating the need for systematic drainage after thyroid surgery.
甲状腺手术中的引流一直是一种常规但经验性的做法,没有科学证据支持其益处。我们对3年半期间个人所做的1789例甲状腺切除术进行了回顾性研究。除了甲状腺癌手术伴淋巴结清扫以及需要胸骨切开术的巨大纵隔甲状腺肿外,未进行不引流的病例选择。患者仅按时间顺序分层,根据是否进行引流分为两组(引流组n = 575例,时间为1993 - 1994年;未引流组n = 1214例,时间为1994 - 1996年)。两组均包括毒性甲状腺肿、巨大坠入性压迫性甲状腺肿、双侧手术及再次手术。5例引流患者(0.9%)和5例未引流患者(0.4%)发生了严重的危及生命的血肿,需要再次探查。17例引流患者(2.9%)和6例未引流患者(1.3%)出现了轻微的术后伤口血肿,经保守治疗。根据我们的经验,只要在关闭切口前术野完全干燥,甲状腺手术后可能并非必须进行引流。因此,我们逐步修改了手术策略,以改进细致的止血技术,我们认为这比使用引流更重要。细致的手术技术和消灭死腔使我们观察到出血并发症的发生率显著降低,从而无需在甲状腺手术后进行常规引流。